Security Name | Ticker | % of Net Assets |
---|---|---|
ABBVIE INC | ABBV | 8.47% |
AMGEN INC. | AMGN | 5.28% |
GILEAD SCIENCES, INC. | GILD | 5.02% |
VERTEX PHARMACEUTICALS | VRTX | 4.39% |
ALNYLAM PHARMACEUTICALS | ALNY | 3.45% |
REGENERON PHARMACEUTICALS | REGN | 3.42% |
CORTEVA INC | CTVA | 2.98% |
INSMED INC | INSM | 2.45% |
NATERA INC | NTRA | 2.12% |
ASTRAZENECA PLC ADR | AZN | 2.11% |
BEONE MEDICINES LTD-ADR | BGNE | 2.01% |
BIOGEN IDEC, INC. | BIIB | 1.97% |
ROYALTY PHARMA PLC- CL A | RPRX | 1.83% |
ILLUMINA INC | ILMN | 1.72% |
NEUROCRINE BIOSCIENCES IN | NBIX | 1.63% |
INCYTE CORP | INCY | 1.62% |
VIATRIS INC | VTRS | 1.45% |
EXELIXIS, INC. | EXEL | 1.40% |
BIOMARIN PHARMACEUTICAL | BMRN | 1.39% |
ARGENX SE - ADR | ARGX | 1.38% |
JAZZ PHARMACEUTICALS PLC | JAZZ | 1.38% |
EXACT SCIENCES | EXAS | 1.34% |
IONIS PHARMACEUTICALS, IN | IONS | 1.34% |
UNITED THERAPEUTICS CORP | UTHR | 1.34% |
BRIDGEBIO PHARMA INC | BBIO | 1.31% |
HALOZYME THERAPEUTICS INC | HALO | 1.29% |
MODERNA INC | MRNA | 1.27% |
CRISPR THERAPEUTICS AG | CRSP | 1.24% |
REVOLUTION MEDICINES INC | RVMD | 1.14% |
GUARDANT HEALTH INC | GH | 1.13% |
ALKERMES PLC | ALKS | 1.13% |
LEGEND BIOTECH CORP-ADR | LEGN | 1.12% |
BIONTECH SE-ADR | BNTX | 1.11% |
AVIDITY BIOSCIENCES INC | RNA | 1.07% |
ROIVANT SCIENCES LTD | ROIV | 1.06% |
CYTOKINETICS INC | CYTK | 1.04% |
TG THERAPEUTICS | TGTX | 0.94% |
PTC THERAPEUTICS | PTCT | 0.93% |
AXSOME THERAPEUT | AXSM | 0.92% |
ARROWHEAD PHARMACEUTICALS | ARWR | 0.86% |
VAXCYTE INC | PCVX | 0.85% |
ADMA BIOLOGICS INC | ADMA | 0.83% |
PROTAGONIST THER | PTGX | 0.83% |
NUVALENT INC-A | NUVL | 0.81% |
CRINETICS PHARMACEUTICALS | CRNX | 0.81% |
AKERO THERAPEUTICS INC | AKRO | 0.77% |
ACADIA PHARMACEUTICALS IN | ACAD | 0.76% |
MEDPACE HOLDINGS | MEDP | 0.75% |
ULTRAGENYX PHARM | RARE | 0.71% |
APELLIS PHARMACE | APLS | 0.71% |
VERACYTE INC | VCYT | 0.70% |
AMICUS THERAPEUTICS INC | FOLD | 0.69% |
VIKING THERAPEUTICS INC | VKTX | 0.69% |
IDEAYA BIOSCIENCES INC | IDYA | 0.64% |
BEAM THERAPEUTICS INC | BEAM | 0.64% |
ARCELLX INC | ACLX | 0.63% |
SUMMIT THERAPEUTICS INC | SMMT | 0.62% |
RECURSION PHARMACEUTICALS | RXRX | 0.60% |
AGIOS PHARMACEUT | AGIO | 0.58% |
DYNE THERAPEUTICS INC | DYN | 0.57% |
SAREPTA THERAPEU | SRPT | 0.57% |
TWIST BIOSCIENCE CORP | TWST | 0.56% |
CELLDEX THERAPEUTICS INC | CLDX | 0.56% |
MADRIGAL PHARMAC | MDGL | 0.56% |
ASCENDIS PHA-ADR | ASND | 0.55% |
INTELLIA THERAPE | NTLA | 0.52% |
DENALI THERAPEUT | DNLI | 0.52% |
NOVAVAX INC | NVAX | 0.51% |
DYNAVAX TECHNOLOGY | DVAX | 0.47% |
IMMUNOVANT INC | IMVT | 0.44% |
KRYSTAL BIOTECH INC | KRYS | 0.41% |
SOLENO THERAPEUTICS INC | SLNO | 0.40% |
IOVANCE BIOTHERAPEUTICS | IOVA | 0.22% |
Other (Cash, derivatives and other liabilities) | 0.47% | |
Total: |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Wealth Solutions, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, GS GAMMA Advisors, LLC, and Guggenheim Private Investments, LLC.
© 2025 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.